BMY FY 2024 Earnings — Bristol-Myers Squibb Company Revenue & Financial Results | Market Cap Arena

BMYBristol-Myers Squibb Company

$124B

FY 2024 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$48.3B+7.3% YoY

Gross Profit

$27.4B56.8% margin

Operating Income

$9.7B20.0% margin

Net Income

-$8.9B-18.5% margin

EPS (Diluted)

$-4.41

Cash Flow

Operating Cash Flow

$15.2B

Free Cash Flow

$13.9B

Stock-Based Comp.

$507M

Balance Sheet

Total Assets

$92.6B

Total Liabilities

$76.2B

Stockholders' Equity

$16.3B

Cash & Equivalents

$10.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$48.3B	$45.0B	+7.3%
Gross Profit	$27.4B	$25.4B	+8.2%
Operating Income	$9.7B	$8.5B	+14.0%
Net Income	-$8.9B	$8.0B	-211.5%